168 related articles for article (PubMed ID: 34814389)
1. [Expert consensus on antiviral therapy for HBV/HCV-related hepatocellular carcinoma: a 2021 update].
Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):948-966. PubMed ID: 34814389
[TBL] [Abstract][Full Text] [Related]
2. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era.
Kaplan DE; Medvedeva E; Serper M
J Viral Hepat; 2020 Oct; 27(10):1082-1092. PubMed ID: 32484991
[TBL] [Abstract][Full Text] [Related]
3. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Yeh ML; Hung CH; Tseng KC; Lai HC; Chen CY; Kuo HT; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang CF; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Liu CJ; Yu ML
Hepatol Int; 2021 Oct; 15(5):1109-1121. PubMed ID: 34365587
[TBL] [Abstract][Full Text] [Related]
5. [Expert consensus on antiviral therapy to treat hepatitis B/C virus-related hepatocellular carcinoma].
Ye S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):321-6. PubMed ID: 25222971
[No Abstract] [Full Text] [Related]
6. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
7. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
8. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ
Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361
[TBL] [Abstract][Full Text] [Related]
9. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.
Kanda T; Lau GKK; Wei L; Moriyama M; Yu ML; Chuang WL; Ibrahim A; Lesmana CRA; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Kadir Dokmeci A; Mamun-Al-Mahtab ; McCaughan GW; Wasim J; Crawford DHG; Kao JH; Ooka Y; Yokosuka O; Sarin SK; Omata M
Hepatol Int; 2019 Nov; 13(6):649-661. PubMed ID: 31541423
[TBL] [Abstract][Full Text] [Related]
10. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
Wirth TC; Manns MP
Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
Khera L; Paul C; Kaul R
Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
Zhang YQ; Guo JS
World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
[TBL] [Abstract][Full Text] [Related]
13. Comment on "Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis".
Mo HY; Xiang BD; Zhong JH; Li LQ; You XM
Can J Gastroenterol Hepatol; 2016; 2016():7625982. PubMed ID: 27500539
[No Abstract] [Full Text] [Related]
14. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
Li L; Lan X
J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
[TBL] [Abstract][Full Text] [Related]
15. Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
Tomova R; Antonov K; Ivanova A; Jacobs JJ; Koten JW; Den Otter W; Krastev Z
Anticancer Res; 2009 Dec; 29(12):5241-4. PubMed ID: 20044643
[TBL] [Abstract][Full Text] [Related]
16. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.
Yang D; Zuo C; Wang X; Meng X; Xue B; Liu N; Yu R; Qin Y; Gao Y; Wang Q; Hu J; Wang L; Zhou Z; Liu B; Tan D; Guan Y; Zhu H
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1264-73. PubMed ID: 24616513
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents.
Chen Q; Ayer T; Adee MG; Wang X; Kanwal F; Chhatwal J
JAMA Netw Open; 2020 Nov; 3(11):e2021173. PubMed ID: 33206188
[TBL] [Abstract][Full Text] [Related]
18. Role of antiviral therapy in the management of hepatocellular carcinoma.
Guan YS; He Q
Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
[TBL] [Abstract][Full Text] [Related]
20. The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Ann Surg Oncol; 2019 Dec; 26(13):4566-4575. PubMed ID: 31602577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
